Resistance	Microbe	Outcome
Oxytetracycline /	Escherichia coli	See: Table 2 AMR+ (%) AMR- (%) Total (n) Use of Tetracyclines 83.30 66 No Use of Tetracyclines 60.40 356
Ampicillin /	Escherichia coli	See: Table 2 AMR+ (%) AMR- (%) Total (n) Use of Tetracyclines 36.40 66 No Use of Tetracyclines 21.90 356
Dihydrostreptomycin /	Escherichia coli	See: Table 2 AMR+ (%) AMR- (%) Total (n) Use of Tetracyclines 69.70 66 No Use of Tetracyclines 44.10 356
Kanamycin /	Escherichia coli	See: Table 2 AMR+ (%) AMR- (%) Total (n) Use of Tetracyclines 24.20 66 No Use of Tetracyclines 14.30 356
Trimethoprim /	Escherichia coli	See: Table 2 AMR+ (%) AMR- (%) Total (n) Use of Tetracyclines 34.80 66 No Use of Tetracyclines 21.60 356